MEIHAO GROUP (01947) announced its interim results, reporting a loss attributable to shareholders of 9.401 million yuan, a year-on-year decrease of 6.06%.

MEIHAO GROUP (01947) announced its interim results for the six months ended June 30, 2026, reporting revenue of 57.638 million yuan (RMB), a year-on-year increase of 32.29%; the loss attributable to equity holders of the parent company was 9.401 million yuan, narrowing by 6.06% compared to the previous year; basic loss per share was 1.61 cents. The announcement stated that the increase in revenue was primarily due to the group's continuous optimization of operational management across its various campuses, strengthening the physician team, and enhancing digital diagnostic capabilities; the cumulative effects of dental implants continued to manifest, with further release of rigid market demand. The group launched competitive dental implant service packages, leading to a significant increase in the number of implant cases. At the same time, the group continued to expand its customer channels and optimize the patient service experience, with steady growth in new customer acquisition and returning patients, driving the overall scale of medical services to continue expanding.